Scarica l'app Stockscreener
12.52
7.66%
0.84
Dopo l'orario di chiusura:
12.52
Precedente Chiudi:
$11.68
Aprire:
$11.5
Volume 24 ore:
50,518
Relative Volume:
2.12
Capitalizzazione di mercato:
$132.04M
Reddito:
$72.33M
Utile/perdita netta:
$-8.38M
Rapporto P/E:
-15.89
EPS:
-0.7881
Flusso di cassa netto:
$-4.95M
1 W Prestazione:
+4.88%
1M Prestazione:
+42.41%
6M Prestazione:
-25.99%
1 anno Prestazione:
+48.12%
Intervallo 1D:
$11.10
$13.38
Intervallo di 1 settimana:
$10.70
$13.38
Portata 52W:
$6.79
$41.72
Burning Rock Biotech Ltd Adr Stock (BNR) Company Profile
Nome
Burning Rock Biotech Ltd Adr
Settore
Industria
Telefono
-
Indirizzo
-
Compare BNR vs TMO, DHR, NTRA, IQV, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BNR
Burning Rock Biotech Ltd Adr
|
12.52 | 129.51M | 72.33M | -8.38M | -4.95M | -0.7881 |
TMO
Thermo Fisher Scientific Inc
|
648.55 | 225.48B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
208.52 | 140.70B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
345.32 | 47.41B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
269.06 | 43.09B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
153.62 | 41.42B | 7.23B | 1.41B | 1.09B | 4.979 |
Burning Rock Biotech Ltd Adr Stock (BNR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2020-07-07 | Iniziato | Cowen | Outperform |
Burning Rock Biotech Ltd Adr Borsa (BNR) Ultime notizie
Burning Rock Biotech (BNR) Earnings Date and Reports 2026 $BNR - marketbeat.com
Aesthetic Medical International Holdings Group Ltd (AIH) Peer Comparison – Compare with Others - Value Research
Concord Medical Services Holdings LimitedADR Peer Comparison – Compare with Others - Value Research
Burning Rock Biotech Ltd StockBNR Share Price Today, News and Discussion - Stocktwits
Burning Rock Biotech (NASDAQ:BNR) Stock Price Down 3.7%What's Next? - MarketBeat
Price to sales forward of Burning Rock Biotech Ltd. Sponsored ADR – FWB:6BU0 - TradingView
Burning Rock Biotech Limited Sponsored ADR $BNR Shares Sold by Crcm LP - MarketBeat
Price to sales forward of Burning Rock Biotech Ltd. Sponsored ADR – SWB:6BU0 - TradingView
Enterprise value to EBITDA forward of Burning Rock Biotech Ltd. Sponsored ADR – SWB:6BU0 - TradingView
Enterprise value to revenue forward of Burning Rock Biotech Ltd. Sponsored ADR – SWB:6BU0 - TradingView
Burning Rock CEO purchases $618,218 in company shares - Investing.com
Burning Rock Announces Founder’s Purchase of Its ADSs - Barchart.com
Burning Rock Biotech Ltd. Sponsored ADR Financial Disclosures & Filings - TradingView
Enterprise value to EBIT forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Enterprise value to revenue forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Price to book forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Price to earnings forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Burning Rock Biotech Ltd. Sponsored ADR Actuals & Estimates (NASDAQ:BNR) - TradingView
Burning Rock Biotech Ltd. Sponsored ADR Actuals & Estimates (LS:A40AE6) - TradingView
Why These High-Flying Stocks Came Back To Earth - Sahm
BNRBurning Rock Biotech Ltd ADR Stock Price and Quote - Finviz
Which countries contribute most to Burning Rock (BNR) revenue? (Overhead Buying) 2026-05-01Momentum ETF - newsline.com
ETFs Investing in Burning Rock Biotech Ltd. Sponsored ADR Stocks - TradingView
Burning Rock Biotech Limited Sponsored ADR (NASDAQ:BNR) Short Interest Update - MarketBeat
Earnings BeforeStock ScreenerSnapshot - Finviz
Burning Rock Biotech (NASDAQ: BNR) 2025 loss narrows amid China and HFCAA risks - Stock Titan
Burning Rock Biotech (NASDAQ:BNR) Stock Price Down 1.3%What's Next? - MarketBeat
Cancer screening company Faces Tough IPO Test As Market Cools - Benzinga
Aurelion Inc. appoints Yuki Xu as acting chief accounting officer By Investing.com - Investing.com South Africa
Aurelion Inc. appoints Yuki Xu as acting chief accounting officer - Investing.com
Burning Rock Biotech (NASDAQ:BNR) Director Purchases $5,466,143.20 in Stock - MarketBeat
Burning Rock CEO purchases $546,604 in company shares - Investing.com
Burning Rock CEO purchases $546,604 in company shares By Investing.com - Investing.com India
Burning Rock Biotech (BNR) Expected to Announce Earnings on Tuesday - MarketBeat
Burning Rock Biotech (NASDAQ:BNR) Stock Price Down 9.8%Here's What Happened - MarketBeat
(BNR) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results - Barchart.com
Intel and AMD among market cap stock movers on Friday By Investing.com - Investing.com Australia
Alibaba and Facebook among market cap stock movers on Thursday - Investing.com
Burning Rock Announces Results of 2025 Annual General Meeting - Barchart.com
This Undiscovered Biotech Stock Has Quintupled in a Year and Just Hit New Highs - Yahoo Finance
Burning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer - Barchart.com
BNR: Revenue up 9.6% and net loss narrowed, with strong pharma R&D and cost controls - TradingView
BNR: Net loss narrowed 89% year-over-year as pharma R&D revenue surged and margins improved - TradingView
BNR: 2024 revenue fell 4% to RMB515.8M, net loss narrowed 47%, in-hospital segment now leads - TradingView
BNR: Commercial breakeven reached in FY2024, with strong margins and leadership in early cancer detection - TradingView
US Stock Market Trends: Updated Data Analysis & Real-Time Quotes - TradingKey
BNR: Net loss narrowed and gross margin improved as in-hospital and pharma R&D revenues grew - TradingView
BNR: In-hospital revenue rose 11.2% and net loss narrowed as the business shifted away from central-lab testing - TradingView
Japan Multi Cancer Early Detection Market Outlook, 2030 - Grand View Research
Burning Rock Biotech Ltd Share Price ADR Each Representing 10 Ord A Shares SPON - Hargreaves Lansdown
Burning Rock Biotech Ltd Adr Azioni (BNR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Burning Rock Biotech Ltd Adr Azioni (BNR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Han Yusheng | Director |
Jun 12 '26 |
Buy |
9.25 |
210,000 |
1,942,143 |
17,907,436 |
| Han Yusheng | Director |
Jun 16 '26 |
Buy |
9.00 |
111,110 |
999,957 |
18,018,546 |
| Han Yusheng | Director |
Jun 22 '26 |
Buy |
7.45 |
104,650 |
779,674 |
18,123,196 |
| Han Yusheng | Director |
Jun 11 '26 |
Buy |
8.74 |
24,760 |
216,388 |
17,697,436 |
| Han Yusheng | Director |
Jun 26 '26 |
Buy |
8.00 |
24,900 |
199,090 |
18,404,086 |
| Han Yusheng | Director |
Jun 23 '26 |
Buy |
7.50 |
5,990 |
44,920 |
18,129,186 |
| Han Yusheng | Director |
Mar 31 '26 |
Buy |
17.36 |
314,870 |
5,466,143 |
17,672,676 |
0.31%
4.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):